NCT03369613

Brief Summary

There are two phases. Phase I: A single visit which includes a screening, clinical scales, and a MRI scan with simultaneous tES/sham tES in a randomized block design. Enrolls both Cervical Dystonia (CD) patients and healthy controls. Phase II: 5 consecutive days of 30-90 min visits to campus for tES or sham tES. Transcranial magnetic stimulation (TMS) measures and clinical scales will also be included on Day 1 and Day 5 visits. Enrolls only CD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 27, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 29, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 12, 2017

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2021

Completed
Last Updated

April 25, 2022

Status Verified

April 1, 2022

Enrollment Period

3.9 years

First QC Date

November 29, 2017

Last Update Submit

April 21, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Phase I: A change in brain functional connectivity in primary cervical dystonia

    A change in mean functional connectivity between the pallidum and putamen during a resting state in CD patients during inhibitory tACS targeting the sensorimotor network.

    Day 1

  • Phase II: Improvement in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) score

    A change in TWSTRS scores following five daily sessions of inhibitory tACS.

    Day 1, Day 5

Study Arms (6)

MRI - HC tDCS

ACTIVE COMPARATOR

Healthy controls in Phase 1 transcranial electrical stimulation set to direct current

Device: transcranial electrical stimulation

MRI - HC tACS

ACTIVE COMPARATOR

Healthy controls in Phase 1- transcranial electrical stimulation set to alternating current

Device: transcranial electrical stimulation

MRI - CD tCDS

ACTIVE COMPARATOR

Cervical dystonia in Phase 1 transcranial electrical stimulation set to direct current

Device: transcranial electrical stimulation

MRI - CD tACS

ACTIVE COMPARATOR

Cervical dystonia in Phase 1 transcranial electrical stimulation set to alternating current

Device: transcranial electrical stimulation

Phase II - Stim

ACTIVE COMPARATOR

Cervical dystonia in Phase 2 transcranial electrical stimulation setting is active

Device: transcranial electrical stimulation

Phase II - Sham

SHAM COMPARATOR

Cervical dystonia in Phase 2 transcranial electrical stimulation setting is sham

Device: transcranial electrical stimulation

Interventions

The device is a Neoprene headcap that holds an array of padded electrodes close to the scalp to stimulate the underlying brain.

MRI - CD tACSMRI - CD tCDSMRI - HC tACSMRI - HC tDCSPhase II - ShamPhase II - Stim

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Right-handed
  • On a stable dose of all medications used to treat dystonia for the month previous to enrollment
  • No botox injections in the 10 weeks previous to enrollment

You may not qualify if:

  • Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
  • Evidence on neurological exam of any potentially confounding neurological disorder
  • Evidence of significant cognitive impairment
  • Patients with dystonia symptoms beginning prior to the age of 18 will be excluded
  • Patients with secondary dystonia resulting from medications or that are part of another neurological disorder (e.g. Parkinson's disease) will be excluded
  • Medication that might predispose the subject to seizures
  • Healthy Controls
  • \- Right-handed
  • Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
  • Evidence on neurological exam of any potentially confounding neurological disorder
  • Evidence of significant cognitive impairment
  • Medication that might predispose the subject to seizures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Denver

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Cervical Dystonia, Primary

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Brian Berman, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2017

First Posted

December 12, 2017

Study Start

October 27, 2017

Primary Completion

September 20, 2021

Study Completion

September 20, 2021

Last Updated

April 25, 2022

Record last verified: 2022-04

Locations